CTRI/2023/05/052517已完成Unknown
A prospective, multi-centre, randomized, parallel arm, open label, control groupstudy to evaluate the efficacy of Mulmina Apple in children with mild tomoderate Attention Deficit Hyperactivity Disorder (ADHD).
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i. Children aged 6 to 12 years with mild to moderate ADHD.
- •ii. Diagnosis of ADHD according to DSM-5 (Diagnostic and Statistical Manual of
- •Mental Disorders-5) criteria.
- •iii. Children with low IQ assessment score (IQ range below 70) as per ICD-10.
- •iv. Subjects willing to consume Mulmina Apple drink regularly.
- •v. Agree to follow protocol procedures and come for follow up visits.
排除标准
- •1.Children having cerebral palsy physical disability and children requiring IEP with epilepsy will be excluded from the study
- •2.Patients with preexisting severe systemic disease necessitating long term medication.
- •3.Any major medical comorbid conditions
- •4.Evidence of significant uncontrolled co morbid disease which in the investigators opinion would jeopardize patient participation
- •5.Any onco other neurological congenital or acquired vascular or systemic disorder which could affect any of the efficacy assessments.
- •6.Participation in the current or previous treatment with any approved or investigational health supplements during the past 1 month
研究者
相似试验
招募中
2 期
A comparative clinical study to evaluate efficacy and safety of test drug in patients with Acute Ischemic strokeCTRI/2021/06/034395Reliance Life Sciences Pvt Ltd
已完成
不适用
A prospective,multicenter, randomized, parallel-group,open-label study of aripiprazole in the management of patients with schizophreniaSchizophreniaJPRN-UMIN000001650Department of Psychiatry, Graduate School of Medicine, Chiba University300
进行中（未招募）
1 期
DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19COVID-19EUCTR2020-001409-21-ESFFIS120
Unknown
3 期
A comparative study to determine the efficacy and safety of Brinzolamide 1% ophthalmic suspension of Cipla Ltd., India against Azopt® of Alcon Pharma Ltd., US in subjects with chronic open angle glaucoma or ocular hypertension.CTRI/2015/05/005760Cipla Ltd
尚未招募
3 期
Efficacy and Safety of Fixed Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate in Comparison to Leuprolide in Heavy Menstrual Bleeding Associated With Uterine FibroidsCTRI/2024/06/068615Sun Pharmaceutical Industries Limited (SPIL)